Delving into the Newest ADC Technologies: Site-Specific Conjugation Based on Transglutaminase
Time: 12:00 pm
day: Track A - Day 2
Details:
- Explore site-specific conjugation based on bacterial transglutaminase (BTG): platforms with high potential
- Review site-specific conjugation of native vs silent antibodies: positive and negative aspects
- Focus on Innate-Pharma BTG technology
